Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/de/projects/1023-ca209-6k7-intrathecal-administration-of-anti-pd1anti-ctla-4-in-combination-with-systemic-combination-of-anti-pd1anti-ctla-4-in-patients-with-nsclc-without-oncogenic-driver-mutation-or-melanoma-and-newly-diagnosed-leptomeningeal-metastasis-a-multicentric-phase-i-study/publications